{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:05:00Z","timestamp":1790845500675,"version":"4.1.0"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Transitioning from pediatric to adult health care is crucial for the continuity of care for young adults with sickle cell disease. Among 5 pediatric hematology practices participating in the Florida Pediatric Hematology Learning and Action Network, 3 practices lacked transition programs before this quality improvement project.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the implementation of programs to improve care for individuals transitioning from pediatric to adult care for sickle cell disease.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This multicenter observational quality improvement study was conducted at 5 pediatric hematology centers in Florida. All patients with sickle cell disease ages 14 to 21 years without neurocognitive impairment who attended 1 of the 5 centers over the project period were included. Data were analyzed from June 2022 to December 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>The network participated in virtual learning about quality improvement and the Got Transition health care transition framework. Clinics organized transition programs and used the Model for Improvement and plan-do-study-act cycles. Readiness assessments and transition plans were implemented. Data updates were conducted every month. P-charts were created to present aggregate and individual practice improvement.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Percentage of patients with sickle cell disease ages 14 to 21 years attending a clinic at each center with a readiness assessment and a transition plan at least once during the previous 12 months as verified by monthly electronic health record (EHR) audits.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 627 patients who met criteria for transition implementation because of age and diagnosis, 458 patients were assessed (240 male [52.4%] and 218 female [47.6%]). Collective change initiatives included educating the clinical staff about the health care transition framework, establishing processes for identifying eligible patients using the patient roster, and creating reliable processes and procedures to ensure that patients had a readiness assessment and transition plan. Over the 19-month project, monthly EHR reviews of 100% or a sample of 10 random EHRs demonstrated an increase in the aggregate mean percentage of eligible patients with readiness assessment from 68.8% (95% CI, 63.1%-74.5%) to 87.8% (95% CI, 85.6%-89.5%), representing a 27.6% improvement. The aggregate transition plan increased from 58.8% (95% CI, 53.3%-64.2%) to 81.2% (95% CI, 78.9%-83.5%), with sustained metrics for over 12-month-period.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings suggest that collaboration among centers was associated with successful achievement of goals. Educating and sharing responsibilities among all center clinicians, identifying patients ahead of time through EHR reviews and clinic-staff huddles, and having electronic versions of readiness assessment and dot phrases to document plans were associated with sustained outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.4957","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:00:38Z","timestamp":1744729238000},"page":"e254957","source":"Crossref","is-referenced-by-count":6,"title":["Improving Health Care Transition for Young Patients With Sickle Cell Disease Through Quality Network"],"prefix":"10.1001","volume":"8","author":[{"given":"Ofelia A.","family":"Alvarez","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Gann","sequence":"additional","affiliation":[{"name":"Johns Hopkins All Children\u2019s Hospital, St Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Ringdahl","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bansal","sequence":"additional","affiliation":[{"name":"Nemours Health, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farranaz","family":"Alvarez Nunez","sequence":"additional","affiliation":[{"name":"Orlando Health Arnold Palmer, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Slayton","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Kashif","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung","family":"Wynn","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bradley","sequence":"additional","affiliation":[{"name":"Orlando Health Arnold Palmer, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Diener","sequence":"additional","affiliation":[{"name":"Orlando Health Arnold Palmer, Orlando, Florida"},{"name":"Now with Pfizer, Rare Disease Division, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Rivers","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Buchman","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Chatfield","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Heldreth","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Widland","sequence":"additional","affiliation":[{"name":"National Institute for Children\u2019s Health Quality, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz Y.","family":"Bayes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Butts-Dion","sequence":"additional","affiliation":[{"name":"National Institute for Children\u2019s Health Quality, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"4","key":"zoi250215r1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0194","article-title":"Transition planning among US youth with and without special health care needs.","volume":"142","author":"Lebrun-Harris","year":"2018","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250215r2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1017\/cts.2018.338","article-title":"Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: current practices and research priorities.","volume":"2","author":"Lanzkron","year":"2018","journal-title":"J Clin Transl Sci"},{"key":"zoi250215r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103498","article-title":"Biopsychosocial factors related to transition among adolescents and young adults with sickle cell disease: a systematic review.","volume":"167","author":"Rea","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"zoi250215r4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1542\/hpeds.2021-005806","article-title":"Hospital use and mortality in transition-aged patients with sickle cell disease.","volume":"11","author":"Fasipe","year":"2021","journal-title":"Hosp Pediatr"},{"issue":"9","key":"zoi250215r5","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999-2009).","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"zoi250215r6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067341","article-title":"Trends in sickle cell disease mortality: 1979-2020.","volume":"154","author":"Karkoska","year":"2024","journal-title":"Pediatrics"},{"issue":"3","key":"zoi250215r7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care.","volume":"17","author":"Phillips","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"zoi250215r8","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2337\/dc07-2247","article-title":"Evaluation of a systems navigator model for transition from pediatric to adult care for young adults with type 1 diabetes.","volume":"31","author":"Van Walleghem","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"zoi250215r9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2265.2008.03467.x","article-title":"Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach.","volume":"71","author":"Cadario","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"zoi250215r10","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.pedhc.2012.06.004","article-title":"A transition pilot program for adolescents with sickle cell disease.","volume":"26","author":"Hankins","year":"2012","journal-title":"J Pediatr Health Care"},{"issue":"8","key":"zoi250215r11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/MPH.0000000000000427","article-title":"Transitioning adolescents and young adults with sickle cell disease from pediatric to adult health care: provider perspectives.","volume":"37","author":"Stolion","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"zoi250215r12","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.2147\/PPA.S377236","article-title":"Pediatric-adult care transition: perceptions of adolescent and young adult patients with sickle cell disease and their healthcare providers.","volume":"16","author":"Hoegy","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"zoi250215r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2023.107089","article-title":"Sickle Cell Trevor Thompson Transition Project (ST3P-UP) protocol for managing care transitions: methods and rationale.","volume":"126","author":"Osunkwo","year":"2023","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"zoi250215r18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1515\/ijamh-2015-0010","article-title":"Development of a sickle cell disease readiness for transition assessment.","volume":"28","author":"Treadwell","year":"2016","journal-title":"Int J Adolesc Med Health"},{"key":"zoi250215r21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2024-017725","article-title":"Results of a healthcare transition learning collaborative for emerging adults with sickle cell disease: the ST3P-UP study transition quality improvement collaborative.","author":"Osunkwo","year":"2024","journal-title":"BMJ Qual Saf"},{"key":"zoi250215r15","volume-title":"The Improvement Guide: A Practical Approach to Enhancing Organizational Performance","author":"Langley","year":"2009","edition":"2nd ed"},{"key":"zoi250215r20","volume-title":"The Health Care Data Guide: Learning from Data for Improvement","author":"Provost","year":"2022","edition":"2nd ed"},{"key":"zoi250215r14","unstructured":"Got Transition. https:\/\/gottransition.org. Accessed February 9, 2024."},{"key":"zoi250215r16","unstructured":"Institute for Healthcare Improvement. Plan-do-study-act (PDSA) worksheet. Accessed February 9, 2024. https:\/\/www.ihi.org\/resources\/tools\/plan-do-study-act-pdsa-worksheet"},{"key":"zoi250215r17","unstructured":"American Society of Hematology. Welcome to ASH. Accessed December 12, 2023. https:\/\/www.hematology.org\/"},{"key":"zoi250215r19","unstructured":"QIMacros. Lean six sigma and SPC Excel add-in. Accessed December 8, 2023. https:\/\/www.qimacros.com"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2832740\/alvarez_2025_oi_250215_1744112182.3423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:00:41Z","timestamp":1744729241000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2832740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.4957","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}